Bio-Techne (TECH) P/S ratio

P/S ratio today
9.4×

Bio-Techne (TECH) trades at 9.4× its revenue per share for fiscal 2026. At the end of fiscal 2026 (June 30, 2026) its P/S ratio was 9.1×. That is 35.5% higher than the 6.7× of fiscal 2025. Figures as of 18 Nov 2026, 04:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
9.4×
P/S ratio, fiscal 2026
9.1×
Change on fiscal 2025
+35.5%
Highest on record
19.6×fiscal 2021
Lowest on record
6.7×fiscal 2025
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Bio-Techne P/S ratio, in more detail

Today's figure is 2.8% above the fiscal 2026 year-end.

Across the 18 fiscal year-ends on record (2009–2026), the highest was 19.6× in fiscal 2021 and the lowest 6.7× in fiscal 2025. Today's P/S ratio is higher than at 56% of the 18 fiscal year-ends on record; their median is 9.1×.

History · 18 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Bio-Techne P/S ratio, year by year

Bio-Techne (TECH) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today9.4×—$72.63—
20269.1× 35.5% up$70.65$7.74
20256.7× 32.2% down$51.45$7.64
20249.9× 14.5% down$71.65$7.21
202311.6× 9.6% down$81.63$7.02
202212.9× 34.3% down$86.66$6.74
202119.6× 39.0% up$112.57$5.75
202014.1× 24.0% up$66.02$4.69
201911.4× 29.7% up$52.12$4.59
20188.8× 11.9% up$36.99$4.22
20177.8× 7.2% down$29.38$3.75
20168.4× 4.1% up$28.19$3.34
20158.1× 15.3% down$24.62$3.04
20149.6× 16.7% up$23.14$2.42
20138.2× 6.0% down$17.27$2.10
20128.7× 18.3% down$18.55$2.13
201110.7× 34.0% up$20.84$1.95
20108.0× 13.0% down$14.36$1.80
20099.2×—$15.95$1.74

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Bio-Techne and comparable companies
CompanyP/S ratio
DaVita DVA0.8×
Halozyme Therapeutics HALO7.8×
Universal Health Services UHS0.6×
Repligen RGEN14.0×
Bio-Techne TECH9.4×
BioMarin Pharmaceutical BMRN3.5×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on TECH

Bio-Techne, figure by figure

Bio-Techne (TECH) overview: price, valuation and scorecardAll health care companies by market value

Bio-Techne P/S ratio: questions and answers

What is Bio-Techne's P/S ratio?

Bio-Techne (TECH) trades at 9.4× its revenue per share for fiscal 2026. At the end of fiscal 2026 (June 30, 2026) its P/S ratio was 9.1×. That is 35.5% higher than the 6.7× of fiscal 2025.

Is Bio-Techne's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 56% of the 18 fiscal year-ends on record; their median is 9.1×.

What are the highest and lowest P/S ratio figures on record for Bio-Techne?

Across the 18 fiscal year-ends on record (2009–2026), the highest was 19.6× in fiscal 2021 and the lowest 6.7× in fiscal 2025.

How is Bio-Techne's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Techne (TECH) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/TECH/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.